Controlled Exposure of Healthy Nonsmokers to Secondhand and Thirdhand Cigarette Smoke — THS04  

Pollution; Exposure Clinical Trial

Official title: Controlled Human Exposure and THS Generation Core

Status Suspended

Clinical Trial Summary

This study compares the health effects of dermal and inhalational exposure to thirdhand cigarette smoke to those of inhalational exposure to secondhand cigarette smoke in healthy, adult nonsmokers. Our hypothesis is that dermal exposure increases exposure to the tobacco specific carcinogen, NNK and may affect both endothelial function and epidermal integrity.

Clinical Trial Description

Thirdhand cigarette smoke is the smoke chemicals that persist in the environment after smoking. Indoors, they can be found both on surfaces and in the air. Thirdhand smoke derives from secondhand smoke and contains the chemicals that stick to surfaces, are re-emitted into the air and that form by chemical reactions both on surfaces and in the air. Thirdhand smoke can contain higher concentrations of the tobacco-specific nitrosamine and known carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) than secondhand smoke, because nicotine reacts to form NNK in the indoor environment. Dermal exposure to thirdhand smoke includes nicotine, NNK and other tobacco-specific nitrosamines, polycyclic aromatic hydrocarbons, and volatile organic compounds. Inhalational exposure to thirdhand smoke includes nicotine, ultrafine particles and volatile organic compounds. Previous studies have shown that inhalational exposure to secondhand cigarette smoke causes endothelial dysfunction, which is a risk factor for heart disease and heart attacks. ;

Related Conditions & MeSH terms

• Exposure to Pollution
• Pollution; Exposure
• Smoke Inhalation
• Smoke Inhalation Injury

• NCT number: NCT04013256
• Study type: Interventional
• Source: University of California, San Francisco
• Status: Suspended
• Phase: N/A
• Start date: January 20, 2020
• Completion date: October 31, 2024